Azienda Sanitaria Locale To3

At Azienda Sanitaria Locale To3, the clinical trial portfolio is focused on cardiovascular diseases, with studies centered on urgent and chronic heart conditions. The research is aimed at testing new treatment approaches and improving outcomes for patients at risk of serious cardiac events.

• Acute myocardial infarction research exploring faster treatment options for people with symptoms suggestive of a recurrent heart attack
• Heart failure studies in patients with mildly reduced or preserved ejection fraction and systemic inflammation
• Evaluation of new therapies designed to reduce cardiovascular death and major heart-related events

This work reflects a strong clinical interest in both emergency cardiac care and longer-term management of complex heart disease, with the goal of improving patient protection and treatment effectiveness.

Research at this site also addresses the early treatment of suspected acute myocardial infarction, focusing on whether a self-administered therapy can help patients during the first signs of a possible event. The aim is to support faster intervention and better protection for individuals at risk of another heart attack.

• Testing a new approach for use at the onset of chest pain or other warning symptoms
• Studying treatment effectiveness in people with prior AMI risk
• Supporting improved emergency response in cardiology

These studies highlight the site’s interest in practical, patient-centered strategies that may improve outcomes in time-sensitive cardiovascular care.

The Cardiology Department at Azienda Sanitaria Locale To3 is also involved in research on heart failure linked with systemic inflammation, especially in patients with mildly reduced or preserved ejection fraction. This work is designed to evaluate whether targeting inflammation can help lower the risk of worsening disease and heart-related complications.

• HFmrEF and HFpEF as key areas of study
• Investigation of inflammation-related drivers of heart failure
• Assessment of therapies intended to reduce cardiovascular events

Overall, the research emphasizes better long-term management of chronic cardiac conditions through improved treatment strategies and risk reduction.